Evidence map›Paper›PMID 15860547›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2005

The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling.

Thomas Seck, Maria Pellegrini, Ana Maria Florea, Veronique Grignoux, Roland Baron, Dale F Mierke, William C Horne

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2008
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Thomas SeckYale University School of Medicine, Department of Orthopaedics, New Haven, Connecticut 06520, USA.
Maria Pellegrini
Ana Maria Florea
Veronique Grignoux
Roland Baron
Dale F Mierke
William C Horne
Yale University · USBrown University · USRuhr University Bochum · DE

Funding

Calcitonin Regulation of Osteoclast Integrin FunctionsR01AR049879 · NIAMS · YALE UNIVERSITY · PI BARON, ROLAND E · 2003 to 2013
$3.7M
Role of Zfp521 in bone formation and anabolic responsesR01AR057769 · NIAMS · HARVARD MEDICAL SCHOOL · PI BARON, ROLAND E · 2010 to 2014
$3.0M
G PROTEIN RECEPTOR - STRUCTURAL CHARACTERIZATIONR01GM054082 · NIGMS · DARTMOUTH COLLEGE · PI MIERKE, DALE F · 2002 to 2010
$2.6M
Regulation of Osteoclastic Bone Resorption:Role of Cb1bR01DE004724 · NIDCR · YALE UNIVERSITY · PI BARON, ROLAND E · 1985 to 2008
$2.0M
REGULATION OF OSTEOCLASTIC BONE RESORPTIONR37DE004724 · NIDCR · YALE UNIVERSITY · PI BARON, ROLAND E · 1993 to 2002
$998k
Calcitonin Regulation of Osteoclasts: Role of CalpainR56AR049879 · NIAMS · HARVARD MEDICAL SCHOOL · PI HORNE, WILLIAM C · 2008 to 2008
$372k
NIAMS NIH HHS AR-49879NIAMS NIH HHS R01 AR049879NIAMS NIH HHS R01 AR057769NIAMS NIH HHS R56 AR049879NIDCR NIH HHS DE-04724NIDCR NIH HHS R01 DE004724NIDCR NIH HHS R37 DE004724NIGMS NIH HHS GM-54083NIGMS NIH HHS R01 GM054082
6 · The paper itself

Abstract

The CTRdelta e13 splice variant of the rabbit calcitonin receptor, which lacks the 14 amino acids of the seventh transmembrane domain (TMD) that are encoded by exon 13, is poorly expressed on the cell surface, fails to mobilize intracellular calcium or activate Erk, and inhibits the cell surface expression of the full-length C1a isoform. Nuclear magnetic resonance- and fluorescence-activated cell sorter-based experiments showed that the residual seventh TMD of CTRdelta e13 fails to partition into the lipid bilayer, resulting in an extracellular C terminus. Truncating the receptor after residue 397 to delete the cytoplasmic tail resulted in reduced cell surface expression and an inability to mobilize intracellular calcium or activate Erk, but the truncated receptor did not inhibit C1a cell surface expression. In contrast, when the receptor was truncated after residue 374 to eliminate the entire seventh TMD domain and the C-terminal domain, the resulting receptor reduced the cell surface expression of C1a in a manner similar to that of CTRdelta e13. Thus, normal cell surface expression, mobilization of intracellular calcium, and Erk activation requires the cytoplasmic C-terminal tail of the CTR, whereas the absence of the seventh TMD in the transmembrane helical bundle causes the dominant-negative effect on the surface expression of C1a.

Indexed as

AnimalsBlotting, WesternCalciumCell LineCell MembraneCell SeparationCyclic AMPCytoplasmDNAEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFlow CytometryGenes, DominantHumansImmunoprecipitationMagnetic Resonance SpectroscopyCalciumCyclic AMPDNAExtracellular Signal-Regulated MAP KinasesPeptidesProtein IsoformsReceptors, Calcitonin

Identifiers

PMID15860547
PMCPMC1242195
OpenAlexW2102542605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.